Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
Can Botox make Big Pharma attractive? What qualif…
June 27, 201925m 31s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?